14-67627548-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001172.4(ARG2):​c.184+6582G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.205 in 151,900 control chromosomes in the GnomAD database, including 3,975 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 3975 hom., cov: 31)

Consequence

ARG2
NM_001172.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.683

Publications

2 publications found
Variant links:
Genes affected
ARG2 (HGNC:664): (arginase 2) Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exists (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type II isoform encoded by this gene, is located in the mitochondria and expressed in extra-hepatic tissues, especially kidney. The physiologic role of this isoform is poorly understood; it is thought to play a role in nitric oxide and polyamine metabolism. Transcript variants of the type II gene resulting from the use of alternative polyadenylation sites have been described. [provided by RefSeq, Jul 2008]
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Gene-Disease associations (from GenCC):
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.353 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001172.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARG2
NM_001172.4
MANE Select
c.184+6582G>C
intron
N/ANP_001163.1P78540

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARG2
ENST00000261783.4
TSL:1 MANE Select
c.184+6582G>C
intron
N/AENSP00000261783.3P78540
ARG2
ENST00000927904.1
c.184+6582G>C
intron
N/AENSP00000597963.1
ENSG00000286861
ENST00000662787.1
n.2876C>G
non_coding_transcript_exon
Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.205
AC:
31108
AN:
151782
Hom.:
3955
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.357
Gnomad AMI
AF:
0.0866
Gnomad AMR
AF:
0.251
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.228
Gnomad SAS
AF:
0.193
Gnomad FIN
AF:
0.140
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.117
Gnomad OTH
AF:
0.230
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.205
AC:
31178
AN:
151900
Hom.:
3975
Cov.:
31
AF XY:
0.206
AC XY:
15315
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.357
AC:
14787
AN:
41364
American (AMR)
AF:
0.251
AC:
3833
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
370
AN:
3464
East Asian (EAS)
AF:
0.229
AC:
1182
AN:
5166
South Asian (SAS)
AF:
0.195
AC:
938
AN:
4814
European-Finnish (FIN)
AF:
0.140
AC:
1473
AN:
10546
Middle Eastern (MID)
AF:
0.279
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
0.117
AC:
7948
AN:
67974
Other (OTH)
AF:
0.230
AC:
486
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1188
2375
3563
4750
5938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
328
656
984
1312
1640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0803
Hom.:
135
Bravo
AF:
0.223
Asia WGS
AF:
0.217
AC:
757
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
11
DANN
Benign
0.80
PhyloP100
0.68
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12587111; hg19: chr14-68094265; API